dr
william
stewart
us
surgeon
gener
alleg
said
late
time
close
book
infecti
diseas
declar
war
pestil
wide
repeat
statement
turn
urban
legend
never
said
howev
belief
infecti
diseas
success
overcom
pervas
biomed
circlesinclud
among
nobel
laureat
medic
dean
thought
leadersfrom
earli
extend
discoveri
outbreak
pneumonia
legionnair
diseas
caus
newli
describ
bacteria
legionella
spp
awaken
call
public
health
infect
control
profession
first
report
diseas
later
known
aid
discoveri
viru
caus
aid
known
hiv
demonstr
infecti
diseas
would
continu
major
sourc
morbid
mortal
patient
importantli
although
legionella
spp
turn
new
human
pathogen
one
caus
human
diseas
centuri
hiv
new
pathogen
human
origin
trace
simian
immunodefici
virus
primat
public
health
threat
pose
emerg
diseas
well
describ
report
institut
medicin
one
one
sinc
discoveri
legionella
hiv
mani
emerg
infecti
diseas
import
infect
control
implic
review
focu
sever
import
threat
includ
novel
coronavirus
sever
acut
respiratori
diseas
sar
middl
east
respiratori
syndrom
mer
hemorrhag
virus
lassa
ebola
novel
influenza
virus
infect
control
strategi
requir
mitig
associ
public
health
threat
pose
virus
world
health
organ
defin
emerg
infecti
diseas
one
appear
popul
first
time
may
exist
previous
rapidli
increas
incid
geograph
rang
center
diseas
control
prevent
cdc
defin
emerg
infecti
diseas
follow
new
infect
result
chang
evolut
exist
organ
known
infect
spread
new
geograph
area
popul
previous
unrecogn
infect
appear
area
undergo
ecolog
transform
old
infect
reemerg
result
antibiot
resist
known
agent
breakdown
public
health
measur
wilson
describ
basic
concept
infecti
diseas
emerg
follow
emerg
infecti
diseas
complex
infecti
diseas
dynam
new
infect
caus
genuin
new
pathogen
agent
involv
new
reemerg
infect
cross
taxonom
line
includ
virus
bacteria
fungi
protozoa
helminth
concept
microb
caus
diseas
inadequ
incomplet
human
activ
potent
factor
drive
diseas
emerg
social
econom
polit
climact
technolog
environment
factor
shape
diseas
pattern
influenc
emerg
understand
respond
diseas
emerg
requir
global
perspect
conceptu
geograph
current
global
situat
favor
diseas
emerg
import
concept
list
wilson
new
emerg
infect
zoonot
diseas
jump
taxonom
line
infect
human
approxim
known
human
pathogen
zoonot
includ
meet
definit
emerg
reemerg
infecti
pathogen
importantli
pathogen
focu
articl
zoonot
complet
list
pathogen
consid
emerg
via
speci
jump
publish
karesh
et
al
review
zoonot
diseas
result
natur
pathogen
ecolog
circumst
anim
product
extract
natur
resourc
antimicrobi
applic
chang
dynam
diseas
exposur
human
be
stage
emerg
pandem
zoonot
diseas
also
review
mors
et
al
describ
stage
emerg
zoonot
diseas
preemerg
encroach
wildlif
habitat
chang
land
use
local
emerg
expans
wildlifehuman
interfac
exampl
ebola
viru
pandem
emerg
intern
travel
exampl
sar
hiv
aid
pike
et
al
describ
stage
zoonot
diseas
emerg
exclus
anim
primari
human
infect
limit
humantohuman
transmiss
sustain
humantohuman
transmiss
exclus
human
institut
medicin
report
microbi
threat
list
factor
infecti
diseas
emerg
follow
ecolog
chang
includ
caus
econom
develop
land
use
agricultur
dam
chang
water
ecosystem
deforestationreforest
flooddrought
famin
climat
chang
human
demograph
behavior
societ
event
popul
growth
migrat
war
civil
conflict
urban
decay
sexual
behavior
intraven
drug
use
use
highdens
facil
intern
travel
commerc
worldwid
movement
good
peopl
air
travel
technolog
industri
global
food
suppli
chang
food
process
packag
organ
tissu
transplant
drug
caus
immunosuppress
widespread
use
antibiot
microbi
adapt
chang
microbi
evolut
respons
select
environ
breakdown
public
health
measur
curtail
reduct
prevent
program
inadequ
sanit
vector
control
measur
recent
articl
list
follow
factor
influenc
new
reemerg
infect
exot
pet
exot
food
eg
bush
meat
companion
anim
alter
livestock
manag
acquisit
new
virul
factor
pathogen
adapt
new
host
speci
chang
land
use
tourism
transloc
infect
anim
person
climat
chang
influenc
arthropod
last
year
mani
emerg
infecti
diseas
infect
control
import
describ
tabl
emerg
antiinfect
resist
among
microb
also
emerg
threat
us
health
care
facil
import
microorgan
includ
methicillinresist
staphylococcu
aureu
vancomycinresist
enterococci
extendedspectrum
enter
gramneg
bacilli
especi
escherichia
coli
klebsiella
enterobact
carbapenemresist
enterobacteriacea
pathogen
enhanc
virul
recent
year
includ
clostridium
difficil
noroviru
strain
also
concern
continu
outbreak
vaccineprevent
diseas
mump
measl
resurg
pertussi
assess
manag
threat
emerg
infecti
diseas
requir
understand
biolog
pathogen
epidemiolog
clinic
manifest
infect
method
diagnosi
therapi
avail
addit
number
issu
specif
infect
control
tabl
key
inform
infecti
diseas
discuss
detail
articl
provid
tabl
health
care
facil
highli
communic
diseas
manag
plan
tabl
detail
discuss
compon
beyond
scope
articl
detail
inform
best
found
especi
earli
epidem
web
page
local
state
health
depart
center
diseas
control
prevent
world
health
organ
gener
recommend
provid
infect
control
expert
area
place
health
care
facil
personnel
substanti
risk
diseas
acquisit
transmiss
first
inadequ
screen
procedur
patient
enter
health
care
facil
potenti
allow
transmiss
ill
patient
hcp
patient
visitor
second
inadequ
suppli
person
protect
equip
ppe
inadequ
train
hcp
proper
don
dof
procedur
increas
risk
exposur
hcp
anoth
import
issu
use
appropri
antisept
hand
hygien
appropri
surfac
disinfect
howev
natur
emerg
diseas
known
ie
bacteria
nonenvelop
viru
envelop
viru
possibl
determin
proper
antisept
disinfect
even
absenc
studi
exact
infecti
agent
exampl
envelop
viru
eg
lassa
evd
merscov
sarscov
influenza
would
inactiv
agent
activ
veget
bacteria
nonenvelop
virus
mycobacteria
veget
bacteria
would
inactiv
agent
activ
nonenvelop
viru
mycobacteria
import
rememb
alcohol
reduc
activ
nonenvelop
virus
eg
noroviru
activ
spore
eg
c
difficil
lassa
fever
singlestrand
neg
rna
viru
belong
arenavirida
famili
famili
serolog
divid
major
complex
old
world
complex
eg
lassa
viru
mobala
viru
new
world
complex
eg
junin
viru
machupo
viru
sabia
viru
except
lymphocyt
choriomening
viru
viru
speci
show
restrict
geograph
occurr
host
lassa
fever
multimamm
rat
mastomi
natalensi
lassa
fever
endem
subsaharan
west
africa
includ
sierra
leon
liberia
guinea
nigeria
estim
number
lassa
viru
infect
per
year
west
africa
approxim
death
transmiss
lassa
viru
human
occur
commonli
ingest
inhal
viru
mastomi
rodent
shed
viru
urin
drop
direct
contact
materi
touch
soil
object
eat
contamin
food
exposur
nonintact
skin
lead
infect
persontoperson
transmiss
may
occur
exposur
viru
blood
tissu
secret
excret
lassa
virusinfect
individu
nosocomi
transmiss
common
health
care
set
proper
ppe
train
correct
use
ppe
avail
incub
period
rang
day
american
missionari
nurs
becam
ill
lassa
nigeria
two
yale
univers
laboratori
worker
studi
diseas
also
becam
sick
two
nurs
one
laboratori
worker
die
later
identifi
lassa
fever
sinc
multipl
case
import
lassa
fever
report
europ
addit
multipl
import
case
report
unit
state
recent
import
case
unit
state
occur
may
die
infect
sinc
first
descript
lassa
fever
nosocomi
transmiss
emerg
preval
mode
acquisit
infect
largest
nosocomi
seri
occur
nigeria
involv
case
includ
hcp
attack
rate
among
patient
overal
fatal
rate
clinic
manifest
lassa
fever
includ
gradual
onset
fever
nausea
abdomin
pain
sever
sore
throat
cough
conjunct
ulcer
buccal
mucosa
exud
pharyng
cervic
adenopathi
late
complic
includ
sever
swell
head
neck
pleural
pericardi
effus
hemorrhag
complic
less
common
infect
subclin
mild
case
sever
importantli
may
difficult
differenti
lassa
fever
hemorrhag
fever
first
day
ill
present
similar
influenzalik
ill
lack
pathognomon
featur
overal
case
fatal
rate
approxim
observ
case
fatal
rate
among
hospit
patient
diseas
especi
sever
late
pregnanc
matern
death
fetal
loss
occur
case
third
trimest
deaf
occur
patient
surviv
diseas
may
return
within
month
half
affect
lassa
fever
often
diagnos
use
enzymelink
immunosorb
assay
realtim
polymeras
chain
reaction
pcr
use
earli
stage
diseas
intraven
ribavirin
use
success
treat
patient
lassa
fever
effect
use
earli
cours
ill
convalesc
plasma
also
use
therapi
patient
lassa
fever
place
singl
room
special
isol
precaut
similar
use
patient
evd
tabl
hcp
wear
appropri
ppe
similar
use
care
patient
evd
includ
full
bodi
protect
suit
hood
cover
gown
set
glove
respir
face
shield
goggl
publish
data
environment
surviv
germicid
suscept
avail
howev
envelop
viru
like
suscept
quaternari
ammonium
compound
phenol
alcohol
lassa
viru
consid
class
iv
biosafeti
agent
patient
sampl
handl
train
staff
process
suitabl
equip
laboratori
current
vaccin
protect
lassa
fever
evid
support
role
ribavirin
postexposur
prophylaxi
lassa
fever
ebola
caus
nonseg
singlestrand
neg
rna
viru
famili
filovirida
identifi
ebola
viru
speci
known
caus
diseas
human
zair
sudan
tai
forest
formerli
cote
divoir
bundibugyo
fifth
reston
viru
caus
diseas
nonhuman
primat
human
natur
reservoir
host
ebola
viru
remain
unknown
howev
detect
antibodi
ebola
ebola
viru
fragment
fruit
insectivor
bat
highli
suggest
anim
serv
reservoir
past
ebola
outbreak
occur
west
central
africa
includ
democrat
republ
congo
uganda
sudan
gabon
singl
case
caus
laboratori
accid
also
report
russia
england
viru
enter
human
popul
transmiss
sustain
via
persontoperson
spread
enhanc
lack
activ
case
find
isol
quarantin
incub
period
ebola
gener
day
rang
day
infect
transmit
symptomat
person
ebola
transmit
persontoperson
direct
contact
ie
nonintact
skin
via
mucou
membran
contact
blood
bodi
fluid
eg
urin
saliva
sweat
fece
vomit
breast
milk
semen
ill
person
object
eg
needl
syring
contamin
bodi
fluid
ill
person
infect
fruit
bat
primat
recent
sexual
transmiss
viru
recogn
liberia
recent
case
report
person
recov
evd
develop
recrudesc
infect
ebola
viru
recov
protect
bodi
locat
eye
central
nervou
system
ebola
transmit
air
water
howev
africa
may
acquir
handl
bushmeat
contact
infect
bat
hcp
substanti
risk
acquir
ebola
patient
care
world
health
organ
report
septemb
http
wwwwhointcsrdiseaseebolasituationreportsarch
en
sinc
start
epidem
total
confirm
case
occur
health
care
provid
guinea
liberia
sierra
leon
report
death
hcp
unit
state
acquir
ebola
current
outbreak
first
recogn
outbreak
ebola
occur
west
africa
year
sinc
initi
outbreak
zair
sudan
tabl
prepared
manag
highli
communic
emerg
infecti
diseas
gener
comprehens
facil
plan
manag
highli
communic
emerg
infecti
diseas
nestl
plan
emerg
infecti
diseas
within
gener
disast
plan
base
plan
rout
transmiss
infecti
agent
incorpor
incid
command
structur
plan
period
train
key
personnel
plan
plan
includ
care
singl
patient
eg
ebola
manag
larg
number
patient
epidem
eg
novel
influenza
incorpor
commun
local
state
health
depart
offici
screen
signag
appropri
base
threat
highli
communic
diseas
place
sign
everi
entranc
hospit
clinic
includ
follow
epidemiolog
clue
possibl
diseas
exposur
ie
travel
locat
sign
symptom
infect
notifi
patient
visitor
exposur
appropri
sign
symptom
includ
messag
sign
symptom
concern
diseas
telephon
contact
patient
eg
remind
appoint
contact
prior
arriv
health
care
facil
screen
patient
immedi
time
health
care
visit
includ
screen
electron
medic
record
also
alert
medic
record
requir
screen
place
appropri
isol
sign
door
patient
isol
possibl
highli
commun
diseas
diseas
transmit
via
droplet
airborn
rout
emphas
respiratori
hygien
ie
immedi
use
mask
proper
dispos
tissu
emphas
need
proper
hand
hygien
messag
appropri
languag
region
train
frontlin
person
clinic
emerg
depart
appropri
use
person
protect
equip
appropri
person
protect
equip
avail
design
locat
emerg
depart
clinic
immedi
place
patient
privat
room
ideal
access
sink
toilet
possibl
one
meet
standard
diseas
transmit
airborn
rout
ie
neg
pressur
outexhaust
air
air
exchang
per
hour
applic
diseas
transmit
airborn
rout
airborn
isol
room
avail
ideal
place
portabl
higheffici
particul
air
purifi
room
welldefin
process
alert
key
health
care
facil
offici
presenc
patient
possibl
highli
commun
diseas
eg
disast
manag
infect
preventionist
avoid
blood
test
procedur
may
place
laboratori
staff
health
care
personnel
risk
welldefin
safe
method
transport
patient
either
properli
equip
emerg
depart
hospit
facil
abl
safe
care
patient
inpati
care
welldefin
plan
inpati
locat
provid
care
patient
highli
commun
diseas
plan
transport
patient
facil
provid
care
inpati
care
unit
design
area
hot
ie
potenti
contamin
cold
ie
area
contamin
approxim
outbreak
occur
current
outbreak
began
west
africa
involv
guinea
sierra
leon
liberia
case
also
report
nigeria
seneg
spain
mali
unit
kingdom
itali
unit
state
septemb
total
case
laboratoryconfirm
case
death
case
fatal
rate
approxim
moreov
first
time
ebola
cross
intern
boundari
involv
nigeria
mali
cross
contin
europ
north
america
four
case
acquir
unit
state
evd
character
sudden
onset
fever
headach
myalgia
arthralgia
larg
joint
back
pain
typic
day
initi
symptom
gastrointestin
symptom
occur
includ
abdomin
pain
nausea
vomit
diarrhea
macular
maculopapular
skin
rash
may
appear
day
diseas
hemorrhag
less
common
occur
patient
termin
case
develop
dissemin
intravascular
coagul
septic
shock
multiorgan
system
failur
mortal
rang
depend
part
infect
speci
zair
speci
highest
mortal
follow
sudan
speci
approxim
bundibugyo
speci
approxim
tai
forest
speci
low
mortal
although
singl
infect
person
report
reston
speci
caus
subclin
infect
human
pregnant
women
higher
mortal
diagnost
test
achiev
use
realtim
pcr
blood
viral
rna
usual
detect
pcr
day
onset
symptom
therefor
earli
cours
ill
diagnost
test
may
fals
neg
current
approv
therapi
ebola
howev
investig
therapi
includ
immunoglobulin
recov
patient
human
monoclon
antibodi
produc
transgen
use
nicotiana
benthamiana
plant
number
antivir
agent
includ
adenosin
analogu
viral
rnadepend
rna
polymeras
inhibitor
short
interf
rna
addit
multipl
vaccin
platform
develop
clinic
trial
high
mortal
ebola
coupl
low
inocul
dose
requir
initi
infect
led
massiv
public
health
respons
unit
state
includ
screen
public
health
personnel
person
return
epidem
countri
west
africa
develop
special
ebola
treatment
center
train
thousand
hcp
use
special
ppe
minim
risk
ebola
acquisit
patient
care
detail
recommend
screen
ebola
among
potenti
infect
return
travel
manag
patient
evd
avail
cdc
web
page
publish
articl
given
high
volum
diarrhea
vomit
potenti
fomit
transmiss
environment
control
critic
issu
care
ebolainfect
patient
ebola
viru
may
persist
steel
plastic
surfac
day
may
also
persist
liquid
media
prolong
period
sodium
hypochlorit
steril
surfac
within
minut
ethanol
steril
carrier
minut
reduct
ebola
strain
achiev
second
use
follow
povidon
iodin
solut
iodin
alcohol
consist
use
appropri
ppe
strict
adher
don
dof
protocol
crucial
prevent
acquisit
evd
patient
care
key
compon
reduc
hcp
risk
proper
train
ppe
don
dof
ongo
train
maintain
compet
sar
caus
novel
coronaviru
sarscov
phylogenet
distinct
previous
known
human
anim
coronavirus
coronavirus
sarscov
positivestrand
rna
viru
belong
famili
coronavirida
classifi
lineag
cov
sarscovlik
virus
detect
himalayan
palm
civet
raccoon
dog
market
southern
china
ultim
reservoir
felt
chines
horsesho
bat
rhinolophu
sinicu
incub
period
sar
day
wherea
mean
time
symptom
onset
hospit
day
humantohuman
transmiss
occur
commonli
via
droplet
rout
sar
also
transmit
via
contact
direct
indirect
airborn
transmiss
may
occur
aerosol
gener
procedur
attack
rate
sarscov
rang
case
per
exposur
hour
importantli
patient
appear
superspread
case
transmit
sar
contact
independ
risk
factor
superspread
nosocomi
outbreak
includ
minimum
distanc
bed
odd
ratio
wash
chang
facil
staff
perform
resuscit
staff
work
experienc
symptom
sar
patient
requir
oxygen
therapi
sar
patient
requir
noninvas
posit
pressur
ventil
sar
gener
began
high
fever
temperatur
includ
headach
myalgia
peopl
mild
respiratori
symptom
onset
ill
day
patient
develop
dri
cough
diarrhea
present
case
laboratori
abnorm
includ
lymphopenia
slightli
decreas
platelet
count
prolong
coagul
profil
mildli
elev
serum
hepat
enzym
overal
mortal
risk
factor
death
includ
age
year
diabet
mellitu
hepat
b
infect
higher
viral
load
infect
control
issu
sar
epidem
expos
global
weak
infect
control
practic
overal
approxim
infect
person
hcp
area
hong
kong
hanoi
experienc
higher
rate
hcp
infect
respect
infect
control
lesson
learn
sar
review
risk
develop
sar
time
higher
wear
mask
patient
care
activ
risk
factor
acquisit
infect
health
care
provid
includ
contact
respiratori
tract
secret
exposur
bodi
fluid
health
care
provid
eye
mucou
membran
inconsist
use
goggl
gown
cap
perform
aerosolgener
procedur
intub
manual
ventil
chest
physiotherapi
suction
inadequ
patient
placement
proper
isol
room
also
risk
nosocomi
transmiss
handwash
shown
protect
multipl
studi
sarscov
shown
surviv
diarrheal
stool
sampl
day
respiratori
tract
secret
day
room
temperatur
human
coronaviru
hcov
inactiv
within
minut
glutaraldehyd
multipl
quaternari
ammonium
compound
multipl
phenol
use
human
coronaviru
sizun
et
al
demonstr
surviv
virus
aluminum
steril
spong
latex
surgic
glove
hour
use
transmiss
gastroenter
viru
surrog
sar
surviv
isol
gown
document
hour
postinocul
data
inactiv
coronavirus
come
primarili
work
hcov
viru
inactiv
within
minut
glutaraldehyd
multipl
quaternari
ammonium
compound
multipl
phenol
also
inactiv
within
minut
povidoneiodin
chlorhexidin
glucon
alcohol
sarscov
inactiv
use
exposur
time
hypochlorit
mer
new
viral
respiratori
diseas
human
first
describ
caus
novel
coronaviru
lineag
cov
microbiolog
epidemiolog
clinic
manifest
sar
mer
compar
septemb
follow
countri
middl
east
report
case
iran
jordan
kuwait
lebanon
oman
qatar
saudi
arabia
unit
arab
emir
yemen
countri
travelassoci
case
includ
algeria
austria
china
egypt
franc
germani
greec
itali
malaysia
netherland
philippin
republ
korea
thailand
turkey
unit
kingdom
unit
state
unit
state
travelassoci
case
health
care
provid
live
work
saudi
arabia
persontoperson
transmiss
document
unit
state
merscov
zoonot
diseas
transmit
anim
human
origin
viru
fulli
understood
believ
origin
bat
transmit
camel
current
believ
dromedari
singlehump
camel
major
reservoir
host
merscov
anim
sourc
human
mer
may
transmit
person
person
occur
commonli
close
contact
provid
unprotect
care
infect
patient
thu
far
sustain
commun
transmiss
document
merscov
gener
estim
make
sustain
transmiss
unlik
unless
mutat
studi
famili
cluster
hcp
contact
patient
report
low
frequenc
transmiss
ie
howev
increas
transmiss
occur
health
care
set
limit
infect
control
procedur
incub
period
mer
approxim
day
rang
day
mer
epidem
middl
east
recent
year
septemb
world
health
organ
report
total
confirm
case
mer
death
summer
larg
outbreak
mer
report
republ
korea
china
septemb
world
health
organ
report
outbreak
involv
total
confirm
case
republ
korea
n
china
n
death
last
case
mer
infect
republ
korea
report
world
health
organ
juli
cluster
case
report
household
health
care
facil
especi
infect
prevent
control
practic
inadequ
clinic
spectrum
mer
infect
rang
asymptomat
mild
respiratori
symptom
sever
acut
respiratori
diseas
death
typic
symptom
mer
includ
fever
cough
short
breath
pneumonia
common
alway
present
gastrointestin
symptom
vomit
diarrhea
frequent
occur
risk
factor
sever
diseas
includ
older
age
comorbid
eg
chronic
lung
diseas
diabet
immunosuppress
report
mortal
approxim
current
specif
therapi
vaccin
avail
multipl
outbreak
mer
involv
health
care
facil
one
outbreak
involv
patient
receiv
hemodialysi
intens
care
unit
case
fatal
rate
recent
outbreak
south
korea
substanti
transmiss
report
health
care
facil
exampl
hospit
report
singl
primari
case
secondari
case
tertiari
case
hcp
high
risk
acquir
mer
altawfiq
perl
report
case
report
saudi
arabia
june
approxim
hcp
factor
contribut
intrahospit
transmiss
includ
initi
symptom
mer
nonspecif
lead
failur
isol
patient
inadequ
complianc
infect
control
practic
inadequ
health
care
facil
eg
overcrowd
close
proxim
patient
case
use
aerosolgener
procedur
prolong
viral
shed
per
cdc
key
method
prevent
transmiss
mer
health
care
facil
includ
notifi
patient
call
arriv
health
care
facil
travel
middl
east
plu
sign
symptom
mer
strict
adher
respiratori
hygien
clinic
emerg
depart
earli
identif
possibl
patient
prompt
institut
contact
airborn
isol
possibl
case
similar
includ
follow
caus
coronavirus
anim
origin
sever
respiratori
diseas
global
spread
infect
travel
effect
therapi
vaccin
diseas
transmiss
famili
hcp
infect
control
health
care
facil
play
critic
role
limit
transmiss
differ
includ
follow
evid
sustain
humantohuman
transmiss
merscov
limit
evid
superspread
mer
slower
global
spread
mer
like
lower
infect
higher
mortal
mer
compar
sar
may
artifact
ascertain
merscov
shown
recover
hour
steel
plastic
washer
rel
humid
decreas
stabil
observ
aerosol
experi
studi
studi
sarscov
discuss
previous
studi
coronavirus
suggest
surviv
environment
surfac
suffici
time
allow
fomit
transmiss
studi
inactiv
sarscov
previous
discuss
coronavirus
inactiv
within
minut
phenol
reduct
ethanol
reduct
hypochlorit
dilut
minut
decreas
influenza
virus
negativesens
rnaenvelop
virus
belong
orthomyxovirida
famili
caus
agent
influenza
contagi
respiratori
viral
diseas
bird
human
influenza
virus
subdivid
distinct
serotyp
base
genet
antigen
properti
hemagglutinin
neuraminidas
envelop
glycoprotein
express
surfac
viru
particl
respons
viru
bind
relev
host
releas
newli
form
infecti
virion
respect
sixteen
hemagglutinin
neuraminidas
subtyp
detect
wild
aquat
bird
poultri
throughout
world
wherea
new
strain
identifi
bat
speci
influenza
virus
exhibit
drift
year
minor
chang
occasion
shift
major
chang
lead
pandem
influenza
pandem
rel
rare
last
year
multipl
influenza
pandem
like
occur
last
centuri
includ
centuri
centuri
centuri
centuri
first
pandem
centuri
occur
novel
influenza
viru
follow
pandem
novel
addit
influenza
reintroduc
may
caus
laboratori
releas
era
singl
circul
strain
influenza
caus
season
influenza
human
sinc
circul
avian
influenza
bird
flu
infecti
diseas
bird
caus
influenza
strain
infect
may
caus
diseas
bird
rang
mild
ill
may
pass
unnot
rapidli
fatal
diseas
caus
sever
epidem
multipl
subtyp
influenza
avian
origin
report
caus
human
diseas
recent
year
includ
respons
human
infect
north
america
influenza
pandem
outbreak
affect
larg
proport
world
novel
viru
unpredict
recur
event
health
econom
social
consequ
worldwid
influenza
pandem
occur
key
factor
converg
influenza
viru
emerg
abil
caus
sustain
humantohuman
transmiss
human
popul
littl
immun
viru
growth
global
trade
travel
local
epidem
transform
pandem
rapidli
littl
time
prepar
public
health
respons
base
number
case
report
durat
subtyp
isol
like
virus
caus
new
worldwid
pandem
human
case
infect
associ
direct
indirect
contact
infect
live
dead
poultri
viru
subtyp
highli
pathogen
influenza
viru
first
infect
human
poultri
outbreak
hong
kong
sinc
widespread
emerg
spread
asia
europ
africa
becom
entrench
poultri
countri
date
report
countri
infect
person
report
mortal
approxim
incub
period
gener
day
maximum
day
much
longer
incub
period
normal
season
influenza
known
subtyp
includ
viru
subtyp
low
pathogen
influenza
viru
first
infect
resid
shanghai
march
case
report
outsid
china
known
subtyp
includ
human
caus
mild
moder
ill
caus
mild
sever
fatal
ill
date
human
case
infect
report
high
mortal
incub
period
approxim
day
rang
day
initi
symptom
includ
high
fever
usual
temperatur
c
influenzalik
symptom
cough
sore
throat
earli
symptom
may
includ
diarrhea
vomit
abdomin
pain
chest
pain
bleed
nose
gum
characterist
patient
develop
lower
respiratori
tract
symptom
earli
includ
respiratori
distress
hoars
voic
complic
includ
hypoxemia
multipl
organ
dysfunct
secondari
bacteri
infect
case
fatal
rate
much
higher
season
influenza
avian
influenza
virus
transmit
close
contact
infect
poultri
hospit
plan
place
deal
epidem
pandem
influenza
especi
influenza
strain
highli
pathogen
human
easili
spread
person
person
influenza
transmit
contact
droplet
rout
recommend
place
patient
highli
pathogen
influenza
virus
hospit
room
meet
airborn
isol
requir
hcp
wear
glove
isol
gown
respir
power
air
purifi
respir
eye
goggl
face
shield
provid
care
place
galvan
metal
glass
persist
day
room
temperatur
low
high
humid
howev
low
temperatur
persist
day
suscept
hypochlorit
solut
second
current
circul
influenza
strain
suscept
neuraminidas
inhibitor
includ
howev
circul
strain
exhibit
resist
one
must
concern
futur
circul
influenza
strain
may
develop
resist
neuraminidas
inhibitor
vaccin
avail
last
sever
decad
wit
emerg
mani
new
infecti
agent
major
public
threat
health
care
facil
need
polici
plan
place
earli
identif
patient
highli
communic
diseas
immedi
isol
proper
manag
prevent
transmiss
hcp
patient
visitor
health
care
facil
